New osteoporosis drug copycat tested in healthy volunteers
Disease control
ENROLLING_BY_INVITATION
This study tests whether a new drug called SAL023 works like the approved osteoporosis medicine Evenity. It involves 118 healthy Chinese adults who get a single dose of either SAL023 or Evenity. The goal is to compare how the body processes the drug, its safety, and any immune re…
Phase: PHASE1 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC